Burden of liver diseases in the world.
暂无分享,去创建一个
P. Kamath | H. Devarbhavi | Patrick S Kamath | S. Asrani | J. Eaton | Sumeet K Asrani | Harshad Devarbhavi | John Eaton
[1] M. Rela,et al. Liver transplantation in India , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[2] J. Shao,et al. Population-representative Incidence of Acute-On-Chronic Liver Failure , 2016, Journal of clinical gastroenterology.
[3] W. Choe,et al. Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition , 2016, PloS one.
[4] G. Davey Smith,et al. Supplementary Tables , 2009 .
[5] Hao Li,et al. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies , 2015, World Journal of Surgical Oncology.
[6] Aijaz Ahmed,et al. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. , 2014, Hepatology.
[7] Chao-Long Chen,et al. Why does living donor liver transplantation flourish in Asia? , 2013, Nature Reviews Gastroenterology &Hepatology.
[8] Zhen Wang,et al. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[9] M. Miquel,et al. Natural history of patients hospitalized for management of cirrhotic ascites. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[10] Yan Liu,et al. Global Burden of Aflatoxin-Induced Hepatocellular Carcinoma: A Risk Assessment , 2010, Environmental health perspectives.
[11] Min Zheng,et al. Acute‐on‐chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults , 2015, Hepatology.
[12] D. J. Kim,et al. A Prospective Nationwide Study of Drug-Induced Liver Injury in Korea , 2012, The American Journal of Gastroenterology.
[13] H. Bonkovsky,et al. Herbal products and the liver: a review of adverse effects and mechanisms. , 2015, Gastroenterology.
[14] M. Manns,et al. Hepatitis D virus infection—Not a vanishing disease in Europe! , 2007, Hepatology.
[15] H. Thomas,et al. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. , 2002, Journal of hepatology.
[16] A. Burroughs,et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. , 2010, Gastroenterology.
[17] A. George. Compassionate Cities: Public Health and End-of-Life Care , 2006 .
[18] J. Lazarus,et al. Hepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A Systematic Review of Data for Scaling Up Treatment and Prevention , 2014, PloS one.
[19] A. Israni,et al. OPTN/SRTR 2015 Annual Data Report: Liver , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[20] Marc J Gunter,et al. Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment , 2018, The lancet. Diabetes & endocrinology.
[21] G. Hirschfield,et al. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. , 2017, Journal of hepatology.
[22] G. Gores,et al. Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[23] P. Bedossa,et al. Risk factors of fibrosis in alcohol‐induced liver disease , 2002, Hepatology.
[24] M. Manns,et al. Autoimmune hepatitis , 2018, Nature Reviews Disease Primers.
[25] S. Franceschi,et al. Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia , 2011, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[26] K. McGlynn,et al. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. , 2015, Clinics in liver disease.
[27] F. Capron,et al. Excess weight risk factor for alcoholic liver disease , 1997, Hepatology.
[28] Noele P. Nelson,et al. Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease. , 2016, Clinics in liver disease.
[29] B. Ludviksson,et al. The epidemiology and natural history of primary biliary cirrhosis: a nationwide population-based study , 2012, European journal of gastroenterology & hepatology.
[30] H. Devarbhavi. Acute Liver Failure Induced by Anti-infectious Drugs: Causes and Management , 2017, Current Hepatology Reports.
[31] J. Miller,et al. Liver microsomal metabolism of aflatoxin B 1 to a reactive derivative toxic to Salmonella typhimurium TA 1530. , 1972, Cancer research.
[32] H. Dalton,et al. Antibiotic therapy: a major cause of drug-induced jaundice in southwest England , 2007, European journal of gastroenterology & hepatology.
[33] C. Ponsioen,et al. Rising incidence and prevalence of primary biliary cirrhosis: a large population‐based study , 2014, Liver international : official journal of the International Association for the Study of the Liver.
[34] Jacques Ferlay,et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet] , 2013 .
[35] R. Matesanz,et al. How Spain Reached 40 Deceased Organ Donors per Million Population , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[36] C. Mulder,et al. Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands , 2014, Scandinavian journal of gastroenterology.
[37] K. Lindor,et al. Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis , 2004, American Journal of Gastroenterology.
[38] Chien-Jen Chen,et al. Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: A 20‐year cohort study of 3.8 million vaccinees , 2014, Hepatology.
[39] M. Buti,et al. Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population. , 2018, Journal of hepatology.
[40] Y. Li,et al. Comparison of Current Diagnostic Criteria for Acute-On-Chronic Liver Failure , 2015, PloS one.
[41] H. Margolis,et al. Population-Based Surveillance for Acute Liver Failure , 2007, The American Journal of Gastroenterology.
[42] C. Ponsioen,et al. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. , 2012, Journal of hepatology.
[43] Andrew X. Zhu,et al. Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise , 2016, The oncologist.
[44] D. Rockey,et al. Development of a novel clinical staging model for cirrhosis using the Nationwide Inpatient Sample , 2018, Journal of Investigative Medicine.
[45] M. Stepanova,et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[46] Chien-Jen Chen,et al. Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma , 2008, Journal of the National Cancer Institute.
[47] J. Talwalkar,et al. Trends in Chronic Liver Disease-Related Hospitalizations: A Population-Based Study , 2019, The American Journal of Gastroenterology.
[48] J. Neuberger,et al. The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: a prospective study. , 2013, Journal of hepatology.
[49] Y. Chawla,et al. Etiology and mode of presentation of chronic liver diseases in India: A multi centric study , 2017, PloS one.
[50] J. Neyts,et al. Update on hepatitis E virology: Implications for clinical practice. , 2016, Journal of hepatology.
[51] Mohsen Naghavi,et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis , 2014, BMC Medicine.
[52] Ramon Planas,et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. , 2005, The New England journal of medicine.
[53] H. El‐Serag,et al. Epidemiology of viral hepatitis and hepatocellular carcinoma. , 2012, Gastroenterology.
[54] Jason A. Dominitz,et al. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013. , 2015, Gastroenterology.
[55] J. Wendon,et al. Acute liver failure. , 2013, The New England journal of medicine.
[56] A. Urueña,et al. Impact of the Single-dose Immunization Strategy Against Hepatitis A in Argentina , 2014, The Pediatric infectious disease journal.
[57] F. Negro,et al. EASL Clinical Practice Guidelines on hepatitis E virus infection. , 2018, Journal of hepatology.
[58] D. Couper,et al. Heavy daily alcohol intake at the population level predicts the weight of alcohol in cirrhosis burden worldwide. , 2016, Journal of hepatology.
[59] P. Loehrer,et al. Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level , 2007 .
[60] G. D’Amico,et al. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. , 2006, Journal of hepatology.
[61] E. Björnsson,et al. Drug‐induced liver injury in a Swedish University hospital out‐patient hepatology clinic , 2006, Alimentary pharmacology & therapeutics.
[62] M. Merli,et al. Incidence and natural history of small esophageal varices in cirrhotic patients. , 2003, Journal of hepatology.
[63] G. D’Amico,et al. Clinical states of cirrhosis and competing risks. , 2017, Journal of hepatology.
[64] E. Kalaitzakis,et al. Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure , 2015, Scandinavian journal of gastroenterology.
[65] H. El‐Serag,et al. The epidemiology of cholangiocarcinoma. , 2004, Seminars in liver disease.
[66] J. West,et al. The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study , 2010, Alimentary pharmacology & therapeutics.
[67] William M. Lee,et al. Acute liver failure induced by idiosyncratic reaction to drugs: Challenges in diagnosis and therapy , 2018, Liver international : official journal of the International Association for the Study of the Liver.
[68] D. J. Kim,et al. Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis , 2016, World journal of gastroenterology.
[69] Li Yang,et al. Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21 789 patients , 2013, European journal of gastroenterology & hepatology.
[70] G. Lee,et al. Chronic Infection With Camelid Hepatitis E Virus in a Liver Transplant Recipient Who Regularly Consumes Camel Meat and Milk. , 2016, Gastroenterology.
[71] L. Henry,et al. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World. , 2016, Clinics in liver disease.
[72] F. Negro,et al. Hepatitis D virus: an update , 2011, Liver international : official journal of the International Association for the Study of the Liver.
[73] L. Y. Wang,et al. Betel quid chewing as a risk factor for hepatocellular carcinoma: a case-control study , 2001, British Journal of Cancer.
[74] H. Wedemeyer,et al. Hepatitis delta virus , 2011, The Lancet.
[75] Angelique Zeringue,et al. Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. , 2011, Gastroenterology.
[76] K. Jacobsen,et al. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. , 2010, Vaccine.
[77] Guan-Tarn Huang,et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. , 2006, JAMA.
[78] M. Stepanova,et al. Direct and Indirect Economic Burden of Chronic Liver Disease in the United States , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[79] Timothy D Phillips,et al. Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. , 2004, The American journal of clinical nutrition.
[80] G. Song,et al. Liver transplantation in Korea: past, present, and future. , 2015, Transplantation proceedings.
[81] G. Folkers,et al. Incidence of drug-induced liver injury in medical inpatients , 2005, European Journal of Clinical Pharmacology.
[82] J. Izopet,et al. Hepatitis E , 2012, The Lancet.
[83] Thomas Berg,et al. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. , 2017, Journal of hepatology.
[84] B. Henderson,et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[85] John R Lake,et al. The Survival Impact of Liver Transplantation in the MELD Era, and the Future for Organ Allocation and Distribution , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[86] Bernadette A. Thomas,et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.
[87] M. Elazar,et al. A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus–infected mongolians , 2016, Hepatology.
[88] G. McCaughan,et al. Liver transplantation in Australia and New Zealand , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[89] W. Cooksley. What did we learn from the Shanghai hepatitis A epidemic? , 2000, Journal of viral hepatitis.
[90] R. Andrade,et al. Drug-Induced Liver Injury Due to Antimicrobials, Central Nervous System Agents, and Nonsteroidal Anti-Inflammatory Drugs , 2014, Seminars in Liver Disease.
[91] C. Wild,et al. Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries. , 2008, Annual Review of Public Health.
[92] F. Tacke,et al. Liver transplantation in Germany , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[93] C. Ф. Галимова. Хронический гепатит D , 2015 .
[94] M. Plummer,et al. World‐wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma , 2015, Hepatology.
[95] K. Reddy,et al. Survival in infection‐related acute‐on‐chronic liver failure is defined by extrahepatic organ failures , 2014, Hepatology.
[96] Jonathan C. Cohen,et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.
[97] J. Samet,et al. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. , 2004, Journal of the National Cancer Institute.
[98] D. Ribero,et al. Current Status on Cholangiocarcinoma and Gallbladder Cancer , 2016, Liver Cancer.
[99] J. Lazarus,et al. Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. , 2018, Journal of hepatology.
[100] T. Morgan,et al. Alcohol and hepatocellular carcinoma. , 2004, Gastroenterology.
[101] M. M. Rahman,et al. Worldwide trends in diabetes since 1980 : pooled analysis of 751 population-based measurement studies with over 4 . 4 million participants , 2016 .
[102] M. Buti,et al. The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B , 2017, Hepatology.
[103] J. Fonseca,et al. Comment to: "EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease". , 2017, Journal of hepatology.
[104] M. Mcphail,et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. , 2013, Journal of hepatology.
[105] A. Walker,et al. Causes of Death in People with Liver Cirrhosis in England Compared with the General Population: A Population-Based Cohort Study , 2015, The American Journal of Gastroenterology.
[106] P. Hillon,et al. Incidence of drug‐induced hepatic injuries: A French population‐based study , 2002, Hepatology.
[107] Robert Blissett,et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe , 2016, Hepatology.
[108] W. Kim,et al. Epidemiology and Healthcare Burden of Acute-on-Chronic Liver Failure , 2016, Seminars in Liver Disease.
[109] Eliseo Guallar,et al. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. , 2013, American journal of epidemiology.
[110] S. Bird,et al. Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[111] V. Wong,et al. Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis , 2013, Hepatology.
[112] M. Rizzetto. Chronic Hepatitis D; at a Standstill? , 2016, Digestive Diseases.
[113] D. Preen,et al. The evolving epidemiology of hepatocellular carcinoma: a global perspective , 2015, Expert review of gastroenterology & hepatology.
[114] H. Barnhart,et al. Liver injury from herbals and dietary supplements in the U.S. Drug‐Induced Liver Injury Network , 2014, Hepatology.
[115] M. Manns,et al. Cutting edge issues in autoimmune hepatitis. , 2016, Journal of autoimmunity.
[116] H. Grønbæk,et al. Cirrhosis and mortality risks of biopsy‐verified alcoholic pure steatosis and steatohepatitis: a nationwide registry‐based study , 2012, Alimentary pharmacology & therapeutics.
[117] Jürgen Rehm,et al. Global burden of alcoholic liver diseases. , 2013, Journal of hepatology.
[118] William M. Lee,et al. Outcomes in Adults With Acute Liver Failure Between 1998 and 2013 , 2016, Annals of Internal Medicine.
[119] H. Jick,et al. A Review of Epidemiologic Research on Drug‐Induced Acute Liver Injury Using the General Practice Research Data Base in the United Kingdom , 1997, Pharmacotherapy.
[120] G. Gores,et al. Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States , 2017, Cancer.
[121] A. Burroughs,et al. Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study. , 2014, Gastroenterology.
[122] L. Tavoschi,et al. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups , 2018, BMC Infectious Diseases.
[123] P. Haberman,et al. Liver cirrhosis with and without mention of alcohol as cause of death. , 1990, British journal of addiction.
[124] Ahmedin Jemal,et al. Annual Report to the Nation on the Status of Cancer, 1975‐2012, featuring the increasing incidence of liver cancer , 2016, Cancer.
[125] Magnus Rattray,et al. A genetic study of Wilson's disease in the United Kingdom. , 2013, Brain : a journal of neurology.
[126] A. Bergquist,et al. Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis , 2017, Scandinavian journal of gastroenterology.
[127] Giacomo Germani,et al. Renal failure and cirrhosis: a systematic review of mortality and prognosis. , 2012, Journal of hepatology.
[128] M. Yamada,et al. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery , 2016, Journal of Gastroenterology.
[129] Gretchen A. Stevens,et al. The global burden of hepatitis E virus genotypes 1 and 2 in 2005 , 2012, Hepatology.
[130] P. van Damme,et al. Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention. , 2017, Journal of hepatology.
[131] M. Charlton,et al. The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health , 2016, Hepatology.
[132] M. Mondelli,et al. Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. , 2009, Journal of hepatology.
[133] A. Nicolucci,et al. The Burden of NAFLD and Its Characteristics in a Nationwide Population with Type 2 Diabetes , 2016, Journal of diabetes research.
[134] F. Gottrand,et al. The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration , 2017, Hepatology.
[135] Terry M. Therneau,et al. Underestimation of liver-related mortality in the United States. , 2013, Gastroenterology.
[136] J. Jónasson,et al. Long term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease , 2014, BMC Gastroenterology.
[137] K. Lindor,et al. Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[138] Å. Danielsson,et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. , 1996, Gut.
[139] A. Urueña,et al. Single-dose Universal Hepatitis A Immunization in One-year-old Children in Argentina: High Prevalence of Protective Antibodies up to 9 Years After Vaccination , 2016, The Pediatric infectious disease journal.
[140] H. El‐Serag,et al. Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go? , 2014, Hepatology.
[141] Hai-rim Shin,et al. Epidemiology of cholangiocarcinoma: An update focusing on risk factors , 2010, Cancer science.
[142] T. Gruenberger,et al. Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[143] J. Rehm,et al. Alcohol and Mortality , 2014, Alcohol Research : Current Reviews.
[144] V. Bhatia,et al. A 20‐year single‐center experience with acute liver failure during pregnancy: Is the prognosis really worse? , 2008, Hepatology.
[145] A. Chetwynd,et al. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. , 2002, Gastroenterology.
[146] F. D. de Abajo,et al. Acute and clinically relevant drug-induced liver injury: a population based case-control study. , 2004, British journal of clinical pharmacology.
[147] A. Bergquist,et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. , 2002, Journal of hepatology.
[148] U. Nöthlings,et al. Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. , 2011, Journal of the National Cancer Institute.
[149] Katherine M Flegal,et al. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. , 2012, JAMA.
[150] A. Zhernakova,et al. Genome-wide association study identifies variants associated with autoimmune hepatitis type 1. , 2014, Gastroenterology.
[151] M. Manns,et al. The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[152] Vikram Patel,et al. Global burden of diseases, injuries, and risk factors for young people's health during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2016, The Lancet.
[153] J. Aronson,et al. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature , 2016, BMC Medicine.
[154] P. Rosenthal,et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. , 2006, The Journal of pediatrics.
[155] O. Traynor,et al. Liver transplantation in Ireland , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[156] T. Karlsen,et al. Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease. , 2016, Gastroenterology.
[157] J. Trotter,et al. Liver transplantation around the world , 2016, Liver transplantation.
[158] Jürgen Rehm,et al. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders , 2009, The Lancet.
[159] Bernadette A. Thomas,et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.
[160] S. Eguchi,et al. Liver transplantation in Japan , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[161] Jennifer L. Lund,et al. Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States. , 2015, Gastroenterology.
[162] Y. Ko,et al. Habitual Betel Quid Chewing and Risk for Hepatocellular Carcinoma Complicating Cirrhosis , 2004, Medicine.
[163] T. Vos,et al. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. , 2016, The Lancet. Infectious diseases.
[164] T. Todorov,et al. Wilson Disease Mutation Pattern with Genotype‐Phenotype Correlations from Western India: Confirmation of p.C271* as a Common Indian Mutation and Identification of 14 Novel Mutations , 2013, Annals of human genetics.
[165] M. Cole,et al. Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team. , 2014, Journal of hepatology.
[166] L. Henry,et al. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.
[167] G. D’Amico,et al. Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients , 2014, Alimentary pharmacology & therapeutics.
[168] Youming Li,et al. Prevalence and Risk Factors for the Development of Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: the Zhejiang Zhenhai Study , 2013, The American Journal of Gastroenterology.
[169] W. Stremmel,et al. EASL Clinical Practice Guidelines: Wilson's disease. , 2012, Journal of hepatology.
[170] M. L. de la Mata,et al. Acute liver failure in Spain: Analysis of 267 cases , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[171] Mathieu Laversanne,et al. International trends in liver cancer incidence, overall and by histologic subtype, 1978–2007 , 2016, International journal of cancer.
[172] C. Couto,et al. Liver Transplantation in Brazil , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[173] Gérard Krause,et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 , 2015, The Lancet.
[174] M. Yuen,et al. Nonalcoholic fatty liver disease in Asia: emerging perspectives , 2017, Journal of Gastroenterology.
[175] G. Esmat,et al. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm , 2014, Journal of viral hepatitis.
[176] C. Pairojkul,et al. Cholangiocarcinoma: lessons from Thailand , 2008, Current opinion in gastroenterology.
[177] T. Therneau,et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. , 2000, Gastroenterology.
[178] William M. Lee,et al. Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study. , 2015, Gastroenterology.
[179] P. Kamath,et al. Time trends in the health care burden and mortality of acute on chronic liver failure in the United States , 2016, Hepatology.
[180] Gretchen A. Stevens,et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults , 2017, Lancet.
[181] B. Li,et al. Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis , 2012, BMC Cancer.
[182] A. Diehl,et al. Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis , 2017, The New England journal of medicine.
[183] E. Björnsson,et al. Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports , 2016, Hepatology.
[184] Detlef Schuppan,et al. Liver cirrhosis , 2008, The Lancet.
[185] E. Rigopoulou,et al. Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in noncirrhotic HBeAg-negative chronic hepatitis B patients: Results from the DARING-B prospective Greek study , 2018 .
[186] S. Kedia,et al. Acute Liver Failure Due to Hepatitis E Virus Infection Is Associated with Better Survival than Other Etiologies in Indian Patients , 2017, Digestive Diseases and Sciences.
[187] A. Moorman,et al. Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[188] Baolin Wang,et al. Causes and Outcomes of Acute Liver Failure in China , 2013, PloS one.
[189] R. Moreau,et al. Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B. , 2016, Scientific Reports.
[190] F. Vleggaar,et al. Population‐based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis , 2013, Hepatology.
[191] D. Corley,et al. Racial and ethnic variations in hepatocellular carcinoma incidence within the United States. , 2008, The American journal of medicine.
[192] W. Kremers,et al. Single-Center Experience With Drug-Induced Liver Injury From India: Causes, Outcome, Prognosis, and Predictors of Mortality , 2010, The American Journal of Gastroenterology.
[193] R. Moreau,et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. , 2013, Gastroenterology.
[194] Ding‐Shinn Chen,et al. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. , 2003, Gastroenterology.
[195] M. Salminen,et al. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening , 2013, BMC Infectious Diseases.
[196] H. Tilg,et al. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. , 2016, Journal of hepatology.
[197] Z. Abbas,et al. Autoimmune liver diseases in the Asia–Pacific region: Proceedings of APASL symposium on AIH and PBC 2016 , 2016, Hepatology International.
[198] C. Fondevila,et al. Liver transplantation in Spain , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[199] Rohit Loomba,et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease , 2017, Hepatology.
[200] T. Therneau,et al. Biliary Tract Cancers in Olmsted County, Minnesota, 1976–2008 , 2012, The American Journal of Gastroenterology.
[201] W. Palmer,et al. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. , 2012, Journal of hepatology.
[202] Yan-Qing Li,et al. Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis , 2011, Cancer Causes & Control.
[203] J. West,et al. All‐cause mortality in people with cirrhosis compared with the general population: a population‐based cohort study , 2012, Liver international : official journal of the International Association for the Study of the Liver.
[204] H. Thomas,et al. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? , 2012, Journal of hepatology.
[205] H. El‐Serag,et al. Risk factors for cholangiocarcinoma , 2011, Hepatology.
[206] H. Kim,et al. Epidemiology, predictors and outcomes of multi drug resistant bacterial infections in patients with cirrhosis across the world. Final results of the “Global study” , 2018 .
[207] P. A. Futreal,et al. Genome-Wide Mutational Signatures of Aristolochic Acid and Its Application as a Screening Tool , 2013, Science Translational Medicine.
[208] H. Vilstrup,et al. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. , 2014, Journal of hepatology.
[209] S. Olafsson,et al. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. , 2013, Gastroenterology.
[210] T. Karlsen,et al. Primary sclerosing cholangitis - a comprehensive review. , 2017, Journal of hepatology.
[211] T. O'Brien,et al. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. , 2006, Journal of the National Cancer Institute.
[212] Alan D. Lopez,et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study , 2017, JAMA oncology.
[213] G. Gores,et al. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. , 2013, Gastroenterology.
[214] A. Burroughs,et al. Impact of primary biliary cirrhosis on perceived quality of life: The UK‐PBC national study , 2013, Hepatology.
[215] Reza Assadi,et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013 , 2016, The Lancet.
[216] Rajvir Singh,et al. Drug‐induced acute liver failure in children and adults: Results of a single‐centre study of 128 patients , 2018, Liver international : official journal of the International Association for the Study of the Liver.
[217] Y. Ni,et al. Hepatitis B vaccination in children: the Taiwan experience. , 2010, Pathologie-biologie.
[218] H. El‐Serag,et al. Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[219] F. Carrat,et al. Large‐scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis , 2017, Hepatology.
[220] J. Neuberger. Liver transplantation in the United Kingdom , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[221] P. Woo,et al. New Hepatitis E Virus Genotype in Bactrian Camels, Xinjiang, China, 2013 , 2016, Emerging infectious diseases.
[222] H. Sørensen,et al. Clinical course of alcoholic liver cirrhosis: A Danish population‐based cohort study , 2010, Hepatology.
[223] A. Bergquist,et al. Epidemiology of cholangiocarcinoma. , 2015, Best practice & research. Clinical gastroenterology.
[224] Jaw-Town Lin,et al. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis. , 2013, Journal of hepatology.
[225] T. Patel. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States , 2001, Hepatology.
[226] E. Ferguson,et al. An international comparison of deceased and living organ donation/transplant rates in opt-in and opt-out systems: a panel study , 2014, BMC Medicine.
[227] L. Serino,et al. Hepatitis A: Epidemiology and prevention in developing countries. , 2012, World journal of hepatology.
[228] J. Trinchet,et al. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features , 2007, Alimentary pharmacology & therapeutics.
[229] B. Graubard,et al. Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States , 2013, The American Journal of Gastroenterology.
[230] L. Scobie,et al. Hepatitis E virus in patients with decompensated chronic liver disease: a prospective UK/French study , 2015, Alimentary pharmacology & therapeutics.